Here’s what Head of Performance Media Josh Palau had to say about how Pfizer currently navigates the CTV landscape, including why having your own hands-on-keyboard experts is key and how new ad formats can be slow to accommodate pharmaceutical brands.
The post Why Pfizer’s Josh Palau Can’t Wait To Buy Netflix Through The Yahoo DSP appeared first on AdExchanger.
More Stories
DoorDash and Live Nation ANZ announce three year partnership
Nielsen survey show magazine audiences on the rise
Google Dodged a Breakup, but Experts Say Alternatives Are Misdirected